Acadia Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
ALKERMES USD 45.63M 8.59M 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Corcept Therapeutics USD 15.38M 3.21M 2024-12
Cytokinetics USD 20.37M 8.79M 2024-12
Eisai JPY 64.53B 1.79B 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Incyte USD 197.46M 18.76M 2024-12
J&J USD 10.31B 1.36B 2024-12
Moderna USD 405M 32M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Pfizer USD 5.63B 319M 2024-12
Prothena USD 7.77M 2.56M 2024-12
PTC Therapeutics USD 17.27M 3.98M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Acadia Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.